EMA Tackles How To Substantiate New Active Substance Claims For Biologics & ATMPs

 
• By Neena Brizmohun
  
Gene therapies are among the products addressed in the new paper on NAS status • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography